Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)Seeking Alpha • 10/27/22
These 2 High-Yield Dividend Aristocrats Are Buffett-Style Table-Pounding Great BuysSeeking Alpha • 10/18/22
Fresenius Medical Care partners with National Kidney Foundation Malaysia in kidney health initiativeBusiness Wire • 09/07/22
CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care PlatformsPRNewsWire • 08/02/22
Fresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend AristocratSeeking Alpha • 07/30/22
Fresenius now expects lower revenue, earnings in the second half, citing wage inflation and staff shortages in North AmericaMarket Watch • 07/28/22
After Plunging 11.8% in 4 Weeks, Here's Why the Trend Might Reverse for Fresenius (FMS)Zacks Investment Research • 07/19/22
Highmark Interactive Inc. Announces Collaboration with Renal Research Institute to Identify Potential Biomarkers of Brain Injury in Hemodialysis PatientsAccesswire • 06/20/22